Lobbying

Inari Medical's latest lobbying report covers Q4 2023, at $50K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.

Inari Medical

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Inari Medical lobbying by quarter
Inari Medical lobbying by quarter
QuarterAmountReports
Q4 2022$50K1
Q1 2023$50K1
Q2 2023$50K1
Q3 2023$50K1
Q4 2023$50K1
Q1 2024$00
Q2 2024$00
Q3 2024$00
Q4 2024$00
Q1 2025$00
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Health issues$158.3K · 5 reports
  • Medicare and Medicaid$58.3K · 3 reports
  • Budget and appropriations$33.3K · 2 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES5 reports
  • SENATE5 reports
  • Centers For Medicare and Medicaid Services (CMS)3 reports
  • Health & Human Services, Dept of (HHS)3 reports

Firms it paid

Firm
Akin Gump Strauss Hauer & Feld$250K5 quarters

Former officials lobbying for it

Former position
FILEMON VELAMbr of Cong, 2013-2022Q2 2023

Lobbying reports

Filed by
24/01/19for Q4 2023Akin Gump Strauss Hauer & Feld$50K
23/10/20for Q3 2023Akin Gump Strauss Hauer & Feld$50K
23/07/20for Q2 2023Akin Gump Strauss Hauer & Feld$50K
23/04/20for Q1 2023Akin Gump Strauss Hauer & Feld$50K
23/01/20for Q4 2022Akin Gump Strauss Hauer & Feld$50K